Blocking small blood vessels for lower back facet joint arthritis pain
Tests blocking spine arteries in people with facet joint arthritis pain.
Key facts
- Who runs it
- Northwell Health
- Where
- Manhasset, United StatesSee the site
- Trial code
- Registry title
- Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 12 Aug 2025
- Expected to end
- 1 Aug 2027
- Type of study
- Interventional
- Treatments tested
- Spinal angiography and embolization/ Embozene Microspheres
- Record updated
- 30 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with long-lasting low back pain from worn facet joints (small joints of the spine). They will test blocking the blood supply to these joints with Embozene microparticles.
- Age
- 18 to 85 years
- Sex
- All sexes
- Disease stage
- Facet joint arthritis seen on MRI or CT. Pain from the facet joints confirmed by test nerve blocks. Back pain for at least 6 months, at least 6/10 on a pain scale. At most 2 spinal levels in the lower back (for example L4-5 and L5-S1). Modified Rankin Scale 0-2, meaning no more than slight disability.
- Earlier treatment
- Pain medicines did not help enough. At least one joint injection of steroids or numbing drugs, or a nerve-burning (neuro-ablative) procedure, did not help.
Main reasons for not taking part
- Pregnancy
- Earlier spinal embolization at the target level, or surgery or stenting of the aorta at that level
- Severe allergic reaction (anaphylaxis) to iodinated contrast dye
- Creatinine > 1.5 mg/dl (133 µmol/L) and/or creatinine clearance < 60 mL/min, unless already on hemodialysis
- Blood vessels feeding the spinal cord come from the vessels to be blocked
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 18-85; Confirmed diagnosis of spinal facet arthropathy on MRI OR CT; Confirmed diagnosis of lumbosacral facetogenic pain based on diagnostic nerve blocks; Failed medical management of pain; Back pain persistent for at least 6 months; Pain worse than at least 6/10 on a visual analog pain scale; Failed at least one of either intra-articular injections of steroids/ anesthetics or neuro-ablative procedure; Maximum of 2 spinal levels of facetogenic pain in the lumbar and sacral spine (i.e. L4-5 and L5-S1); Modified Rankin Scale 0-2
Who cannot take part
- History of prior spinal embolization at the target level
- History of surgery/ stenting of the aorta at the level of embolization
- Severe allergic reaction to iodinated contrast (i.e. anaphylaxis)
- Creatinine > 1.5 mg/dl and/or creatinine clearance < 60 mL/min (except if patients is already on hemodialysis)
- - Pregnancy
- Modified Rankin Scale >2
- Angiographic/ Procedural Exclusion Criterion: Vascular supply to the spinal cord from the vessels supplying the facet joints targeted for embolization
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Where in United States
- North Shore University HospitalManhasset, United StatesContact: Betsy MoclairTaking people
About the trial
What the trial wants to find out
This single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.
The group in the trial
- Embozene Microspheres for Facetogenic Low Back PainTreatment being tested
This is a single site, single arm study to assess the safety and efficacy of trans arterial embolization using Embozene microspheres of the facet joint for the treatment of facetogenic low back pain.
Treatment: Spinal angiography and embolization/ Embozene Microspheres
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Trans Arterial Embolization for Facet Arthropathy
- Plain-language title
- Blocking small blood vessels for lower back facet joint arthritis painGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06965452, who can take part
- Record updated
- 30 October 2026